Tobam Sage Therapeutics, Inc. Transaction History

Tobam

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$25.95 - $43.15 $62,280 - $103,560	-2,400 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$26.15 - $77.24 $39,225 - $115,859	1,500 Added 166.67%	2,400 $69,000
Q4 2019 Feb 10, 2020	BUY	$60.18 - $154.77 $18,054 - $46,431	300 Added 50.0%	900 $65,000
Q3 2019 Nov 12, 2019	BUY	$140.29 - $189.96 $14,029 - $18,996	100 Added 20.0%	600 $84,000
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $78,925 - $91,545	500 New	500 $92,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.